2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

Solomon, 2002, . The 2001 Bethesda System: terminology for reporting results of cervical cytology., JAMA, 287, 2114, 10.1001/jama.287.16.2114

2003, Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance., Am J Obstet Gynecol, 188, 1383, 10.1016/S0002-9378(03)00418-6

2003, A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations., Am J Obstet Gynecol, 188, 1393, 10.1016/S0002-9378(03)00413-7

Wright, 2002, 2001 Consensus guidelines for the management of women with cervical cytological abnormalities and cervical cancer precursors: Part 1: Cytological abnormalities., JAMA, 287, 2120, 10.1001/jama.287.16.2120

Wright, 2003, Wilkinson EJ; 2001 ASCCP-sponsored Consensus Workshop. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia., J Low Genit Tract Dis, 7, 154

Wright, 2007, Solomon D; 2006 ASCCP-Sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical screening tests., J Low Genit Tract Dis, 11, 201, 10.1097/LGT.0b013e3181585870

Davey, 2002, . ASCCP patient management guidelines: Pap test specimen adequacy and quality indicators., J Low Genit Tract Dis, 6, 195, 10.1097/00128360-200207000-00008

Davey, 2008, . Cervical cytology specimen adequacy: Updated patient management guidelines., J Low Genit Tract Dis, 12, 71, 10.1097/LGT.0b013e3181585b9b

Saslow, 2012, . American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer., CA Cancer J Clin, 62, 147, 10.3322/caac.21139

Moyer, 2012, for the U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement., Ann Intern Med, 156, 880, 10.7326/0003-4819-156-12-201206190-00424

Castle, 2008, Risk assessment to guide the prevention of cervical cancer., J Low Genit Tract Dis, 12, 1, 10.1097/lgt.0b013e31815ea58b

Darragh, 2012, ; Members of LAST Project Work Groups. The Lower Anogenital Squamous Terminology Standardization Project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology., J Low Genit Tract Dis, 16, 205, 10.1097/LGT.0b013e31825c31dd

Mogensen, 1997, . Cytobrush and endocervical curettage in the diagnosis of dysplasia and malignancy of the uterine cervix., Acta Obstet Gynecol Scand, 76, 69, 10.3109/00016349709047788

Goksedef, 2013, Diagnostic accuracy of two endocervical sampling method: randomized controlled trial., Arch Gynecol Obstet, 287, 117, 10.1007/s00404-012-2542-9

Kyrgiou, 2006, . The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy and cervical cytopathology collaborative group (C5 group) approach., Cancer Treat Rev, 32, 516, 10.1016/j.ctrv.2006.07.008

Nuovo, 2000, Treatment outcomes for squamous intraepithelial lesions., Int J Gynaecol Obstet, 68, 25, 10.1016/S0020-7292(99)00162-9

Kalliala, 2007, Cancer free survival after CIN treatment: comparisons of treatment methods and histology., Gynecol Oncol, 105, 228, 10.1016/j.ygyno.2006.12.028

Paraskevaidis, 2004, . The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature., Cancer Treat Rev, 30, 205, 10.1016/j.ctrv.2003.07.008

Jakobsson, 2009, Long-term mortality in women treated for cervical intraepithelial neoplasia., BJOG, 116, 838, 10.1111/j.1471-0528.2009.02115.x

Kalogirou, 1997, Predictive factors used to justify hysterectomy after loop conization: increasing age and severity of disease., Eur J Gynaecol Oncol, 18, 113

Ghaem-Maghami, 2007, Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis., Lancet Oncol, 8, 985, 10.1016/S1470-2045(07)70283-8

Kocken, 2012, . High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis., Gynecol Oncol, 125, 500, 10.1016/j.ygyno.2012.01.015

Katki, 2013, . Five-year risk of CIN 3 and cervical cancer among women with HPV testing of ASC-US Pap results., J Low Genit Tract Dis, 17, S36, 10.1097/LGT.0b013e3182854253

Jakobsson, 2009, Loop electrosurgical excision procedure and the risk for preterm birth., Obstet Gynecol, 114, 504, 10.1097/AOG.0b013e3181b052de

Sadler, 2004, Treatment for cervical intraepithelial neoplasia and risk of preterm delivery., JAMA, 29, 2100, 10.1001/jama.291.17.2100

Bruinsma, 2011, The risk of preterm birth following treatment for precancerous changes in the cervix: a systematic review and meta-analysis., BJOG, 118, 1031, 10.1111/j.1471-0528.2011.02944.x

Moscicki, 2010, . Rate of and risks for regression of cervical intraepithelial neoplasia 2 in adolescents and young women., Obstet Gynecol, 116, 1373, 10.1097/AOG.0b013e3181fe777f

Moscicki, 2004, . Regression of low-grade squamous intra-epithelial lesions in young women., Lancet, 364, 1678, 10.1016/S0140-6736(04)17354-6

Katki, 2013, . Five-year risk of CIN 3 to guide the management of women aged 21 to 24 years., J Low Genit Tract Dis, 17, S64, 10.1097/LGT.0b013e3182854399

Moscicki, 2010, Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women., J Low Genit Tract Dis, 14, 73, 10.1097/LGT.0b013e3181cec411

Benard, 2012, Cervical Cancer Rates Among Young Females in the United States., Obstet Gynecol, 120, 1117, 10.1097/AOG.0b013e31826e4609

Winer, 2003, Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students., Am J Epidemiol, 157, 218, 10.1093/aje/kwf180

Moscicki, 2001, . Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females., JAMA, 285, 2995, 10.1001/jama.285.23.2995

Kahn, 2005, . Psychological, behavioral, and interpersonal impact of human papillomavirus and Pap test results., J Womens Health, 14, 650, 10.1089/jwh.2005.14.650

Kahn, 2007, . Personal Meaning of Human Papillomavirus and Pap Test Results in Adolescent and Young Adult Women., Health Psychol, 26, 192, 10.1037/0278-6133.26.2.192

Lerner, 2010, . The impact of pre-cancerous cervical lesions on functioning at work and work productivity., J Occup Environ Med, 52, 926, 10.1097/JOM.0b013e3181f12fb0

Moriarty, 2009, . Unsatisfactory reporting rates: 2006 practices of participants in the College of American Pathologists interlaboratory comparison program in gynecologic cytology., Arch Pathol Lab Med, 133, 1912, 10.5858/133.12.1912

Ransdell, 1997, Clinicopathologic correlation of the unsatisfactory Papanicolaou smear., Cancer (Cancer Cytopathol), 81, 139, 10.1002/(SICI)1097-0142(19970625)81:3<139::AID-CNCR2>3.0.CO;2-M

Siebers, 2012, Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology., Arch Pathol Lab Med, 136, 76, 10.5858/arpa.2011-0113-OA

Zhao, 2009, High-risk human papillomavirus DNA test results are useful for disease risk stratification in women with unsatisfactory liquid-based cytology Pap test results., J Lower Genit Tract Dis, 13, 79, 10.1097/LGT.0b013e31818474fd

Holton, 2008, The effect of lubricant contamination on ThinPrep liquid-based preparations., Cytopathology, 19, 236, 10.1111/j.1365-2303.2007.00525.x

Buntinx, 1996, Relation between sampling device and detection of abnormality in cervical smears: a meta-analysis of randomized and quasi-randomised studies., BMJ, 313, 1285, 10.1136/bmj.313.7068.1285

Huang, 2009, Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia., Aust N Z J Obstet Gynaec, 49, 426, 10.1111/j.1479-828X.2009.01014.x

Mitchell, 2004, Cervical cytology screening history of women diagnosed with adenocarcinoma in situ of the cervix. A case-control study., Acta Cytol, 48, 595, 10.1159/000326428

Mitchell, 2001, Longitudinal analysis of histologic high-grade disease after negative cervical cytology according to endocervical status., Cancer, 93, 237, 10.1002/cncr.9035

Elumir-Tanner, 2011, Management of Papanicolaou test results that lack endocervical cells., CMAJ, 183, 563, 10.1503/cmaj.101156

Zhao, 2007, Human papillomavirus DNA detection in ThinPrep Pap test vials is independent of cytologic sampling of the transformation zone., Gynecol Oncol, 107, 231, 10.1016/j.ygyno.2007.06.025

Huang, 2009, Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia., Aust NZ J Obstet Gynaecol, 49, 426, 10.1111/j.1479-828X.2009.01014.x

Katki, 2013, . Five-year risks of CIN 3 and cervical cancer among women who test Pap-negative but are HPV-positive., J Low Genit Tract Dis, 17, S56, 10.1097/LGT.0b013e318285437b

Rodriguez, 2008, for the Proyecto Epidemiologico Guanacaste Group. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections., J Natl Cancer Inst, 100, 513, 10.1093/jnci/djn044

Stoler, 2011, High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study., Am J Clin Pathol, 135, 466, 10.1309/AJCPZ5JY6FCVNMOT

Einstein, 2010, . Clinical validation of the Cervista HPV HR and 1618 genotyping tests for use in women with ASC-US cytology., Gynecol Oncol, 118, 116, 10.1016/j.ygyno.2010.04.013

Gage, 2010, Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions., Cancer Epidemiol Biomarkers Prev, 19, 1668, 10.1158/1055-9965.EPI-09-1286

Cox, 2003, Prospective follow-up suggests similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy., Am J Obstet Gynecol, 188, 1406, 10.1067/mob.2003.461

Moore, 2010, . Lessons from practice: risk of CIN3 or cancer associated with an LSIL or HPV-positive ASC-US screening result in women aged 21-24., J Lower Genit Tract Dis, 14, 97, 10.1097/LGT.0b013e3181b8b024

Arbyn, 2006, Chapter 9: clinical applications of HPV testing: a summary of meta-analyses., Vaccine, 24, S78, 10.1016/j.vaccine.2006.05.117

Katki, 2013, . Five-year risks of CIN 2 and CIN 3 among women with HPV-positive and HPV-negative LSIL Pap results., J Low Genit Tract Dis, 17, S43, 10.1097/LGT.0b013e3182854269

Katki, 2013, . Follow-up testing after colposcopy: five-year risk of CIN 2 after a colposcopic diagnosis of CIN 1 or less., J Low Genit Tract Dis, 17, S69, 10.1097/LGT.0b013e31828543b1

Massad, 2001, Biopsy correlates of abnormal cervical cytology classified using the Bethesda system., Gynecol Oncol, 82, 516, 10.1006/gyno.2001.6323

Alvarez, 2007, Effective cervical neoplasia detection with a novel optical detection system: a randomized trial., Gynecol Oncol, 104, 281, 10.1016/j.ygyno.2006.08.056

Dunn, 2003, A see and treat management for high grade squamous intraepithelial lesion Pap smears., J Lower Gen Tract Dis, 7, 104, 10.1097/00128360-200304000-00006

Katki, 2013, . Five-year risk of cervical cancer and CIN3 for HPV-positive and HPV-negative high-grade Pap results., J Low Genit Tract Dis, 17, S50, 10.1097/LGT.0b013e3182854282

Pretorius, 2004, . Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of Cervical intraepithelial neoplasia II or worse., Am J Obstet Gynecol, 191, 430, 10.1016/j.ajog.2004.02.065

Gage, 2006, . Number of cervical biopsies and sensitivity of colposcopy., Obstet Gynecol, 108, 264, 10.1097/01.AOG.0000220505.18525.85

Guido, 2003, Solomon D; Burke L for the ASCUSLSIL Triage Study (ALTS) Group. Post-colposcopy management strategies for women referred with low-grade squamous intraepithelial lesions of human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective trial., Am J Obstet Gynecol, 188, 1401, 10.1067/mob.2003.456

Lee, 2002, . Atypical glandular cells of undetermined significance (AGUS): interobserver reproducibility in cervical smears and corresponding thin-layer preparations., Am J Clin Pathol, 117, 96, 10.1309/HL0B-C7Y6-AC77-ND2U

Davey, 2004, Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology., Arch Pathol Lab Med, 128, 1224, 10.5858/2004-128-1224-BIARRP

Zhao, 2009, Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods., Gynecol Oncol, 114, 383, 10.1016/j.ygyno.2009.05.019

Sharpless, 2005, Dysplasia associated with atypical glandular cells on cervical cytology., Obstet Gynecol, 105, 494, 10.1097/01.AOG.0000152350.10875.02

Castle, 2010, Relationship of atypical glandular cell cytology, age and human papillomavirus detection to cervical and endometrial cancer risks., Obstet Gynecol, 115, 243, 10.1097/AOG.0b013e3181c799a3

Simsir, 2005, Reporting endometrial cells in women 70 years and older: assessing the clinical usefulness of Bethesda 2001., Am J Clin Pathol, 123, 571, 10.1309/LJRD8JGJ7E5ERBUW

Schlecht, 2003, . Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia., J Natl Cancer Inst, 95, 1336, 10.1093/jnci/djg037

Sideri, 2011, . Age distribution of HPV genotypes in cervical intraepithelial neoplasia., Gynecol Oncol, 212, 510, 10.1016/j.ygyno.2011.02.018

Trimble, 2005, . Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype., Clin Cancer Res, 11, 4717, 10.1158/1078-0432.CCR-04-2599

Petersen, 2007, Grading of squamous dysplasia in endocervical curettage specimens: The case for conservative management of mild endocervical dysplasia., J Reprod Med, 52, 917

Ostor, 1993, Natural history of cervical intraepithelial neoplasia: A critical review., Intern J Gynecol Pathol, 12, 186, 10.1097/00004347-199304000-00018

Holowaty, 1999, Natural history of dysplasia of the uterine cervix., J Natl Cancer Inst, 91, 252, 10.1093/jnci/91.3.252

Katki, 2013, . Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management., J Low Genit Tract Dis, 17, S78, 10.1097/LGT.0b013e31828543c5

Sherman, 2005, Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival., Cancer, 103, 1258, 10.1002/cncr.20877

Bull-Phelps, 2007, Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix., Gynecol Oncol, 107, 316, 10.1016/j.ygyno.2007.06.021

Costa, 2012, . Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 cases., Gynecol Oncol, 124, 490, 10.1016/j.ygyno.2011.11.039

van Hanegem, 2012, Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix., Gynecol Oncol, 124, 72, 10.1016/j.ygyno.2011.09.006

Lea, 2002, . Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ., Gynecol Oncol, 87, 129, 10.1006/gyno.2002.6791